Why Does CADASIL Raise Brain Bleed and Microbleed Risk?

It is one of the most confusing aspects of a CADASIL diagnosis: if the disease causes the walls of your blood vessels to become abnormally thick, why does that increase your risk of brain bleeds?

The short answer is that in CADASIL, thickness does not equal strength. The vessel walls undergo significant remodeling: abnormal proteins deposit within them, and the living muscle cells that usually provide resilience begin to degenerate ^[1]. This process transforms healthy, dynamic blood vessels into stiffer, less resilient structures that can struggle to regulate blood flow or withstand mechanical stress ^[2][3].

The “Old Rubber Band” Effect

To understand how a blood vessel can be both thick and fragile, it helps to look at what is happening on a cellular level.

Healthy blood vessels have an inner lining surrounded by vascular smooth muscle cells (VSMCs). These muscle cells allow the vessel to expand and contract, absorbing the pulse of your heartbeat and regulating blood flow. Think of them like a fresh, stretchy rubber band.

In CADASIL, a mutation in the NOTCH3 gene causes the NOTCH3 protein to misfold. This leads to the buildup of abnormal deposits known as granular osmiophilic material (GOM) in the walls of small arteries ^[1][4]. As this material accumulates, the vital smooth muscle cells become damaged and degenerate ^[1].

When these living cells are lost, they are often replaced by stiffer tissue, a process called fibrosis ^[2]. The result is a vessel wall that is thicker than normal, but lacks its natural elasticity. It can no longer dilate or constrict properly ^[3]. Like an old, dried-out rubber band, the vessel becomes stiff, less resilient, and more susceptible to structural failure.

Two Distinct Bleeding Risks: Microbleeds vs. Major Hemorrhage

Because the small arteries in the brain lose their normal structural support, their protective barrier can be compromised ^[5]. This leads to two types of bleeding risks, which are very different in terms of frequency and danger:

Important: Finding microbleeds on your MRI does not mean you are actively bleeding or leaking, nor does it guarantee you will have a major hemorrhage. The number and location of CMBs (often in deep areas like the thalamus) help clinicians assess your small-vessel disease, but they are just one piece of your overall health picture ^[8].

🚨 When to Get Emergency Help

If you experience sudden symptoms, do not wait for a routine neurology appointment or attempt to drive yourself to the hospital. Call local emergency services (like 911) immediately if you notice:

• Sudden one-sided weakness or numbness (face, arm, or leg)
• Sudden facial droop or trouble speaking/understanding speech
• Sudden confusion, seizure, or loss of consciousness
• Sudden vision loss or changes
• A sudden, severe “worst-ever” headache

Risk Factors for Major Hemorrhage

While major brain bleeds (ICH) are relatively rare, certain factors can increase the risk of a rupture:

• Sustained High Blood Pressure (Hypertension): Because CADASIL blood vessels are stiff and unable to flex, they struggle to handle sustained mechanical stress. Studies indicate that hypertension is an important modifiable risk factor for experiencing a major brain bleed with CADASIL ^[7]. Regular monitoring and an individualized blood pressure target—set by you and your doctor—are critical. You should not, however, panic over a single high reading or change your medications without guidance.
• Specific Genetic Variations: CADASIL severity varies widely, even among relatives. Observational studies have found that certain specific NOTCH3 mutations—such as the R544C variant and the R75P variant (frequently studied in East Asian cohorts)—are associated with a higher burden of microbleeds and a greater risk of intracerebral hemorrhage ^[9][7]. However, having one of these variants does not guarantee a major bleed; your individual risk is a combination of your age, blood pressure, MRI findings, and overall health.

Managing Medications Carefully

Because of the underlying vascular fragility, medication management requires a careful balancing act. Many CADASIL patients take blood-thinning medications to prevent ischemic strokes (strokes caused by clots), but these same medications can potentially increase the risk of bleeding complications.

• Prescription Blood Thinners (Antiplatelets and Anticoagulants): You must never stop taking a prescribed antiplatelet (like aspirin or clopidogrel) or an anticoagulant without discussing it with your prescribing doctor. The protective benefits against a major ischemic stroke or heart condition often outweigh the bleeding risks. Your neurologist will review your MRI and medical history to make an individualized decision.
• Over-the-Counter NSAIDs and Supplements: Non-steroidal anti-inflammatory drugs (NSAIDs like ibuprofen or naproxen) and high-dose fish oil can have mild blood-thinning effects. While they are not the same class as prescription anticoagulants, you should check with your clinician or pharmacist before starting them to ensure they are safe for your specific situation.